Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-018465
Filing Date
2023-05-16
Accepted
2023-05-16 17:07:36
Documents
5
Effectiveness Date
2023-05-16

Document Format Files

Seq Description Document Type Size
1 S-8 s-8filingx51623.htm S-8 68786
2 EX-FILING FEES exhibit107filingfeetableto.htm EX-FILING FEES 16801
3 EX-5.1 exhibit51opinion-may2023.htm EX-5.1 17709
4 EX-23.1 exhibit231toforms-8xmay2023.htm EX-23.1 2970
5 GRAPHIC image_0.jpg GRAPHIC 278098
  Complete submission text file 0001628280-23-018465.txt   490412
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271978 | Film No.: 23928570
SIC: 2834 Pharmaceutical Preparations